pMal-E6LLO
(Plasmid
#51281)
-
PurposeExpresses a fibronectin fusion with listeriolysin targeting EGFR in bacteria
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 51281 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 | |
This material is available to academics and nonprofits only.
Backbone
-
Vector backbonepMal
-
Backbone manufacturerNEB
- Total vector size (bp) 7800
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)XL1 Blue
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameE6LLO
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
How to cite this plasmid
( Back to top)
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pMal-E6LLO was a gift from Dane Wittrup (Addgene plasmid # 51281 ; http://n2t.net/addgene:51281 ; RRID:Addgene_51281) -
For your References section:
Targeted cytolysins synergistically potentiate cytoplasmic delivery of gelonin immunotoxin. Pirie CM, Liu DV, Wittrup KD. Mol Cancer Ther. 2013 Sep;12(9):1774-82. doi: 10.1158/1535-7163.MCT-12-1023. Epub 2013 Jul 5. 10.1158/1535-7163.MCT-12-1023 PubMed 23832121
